国常会听取国家水网建设情况汇报

Group 1: National Water Network Construction - The meeting highlighted the importance of the national water network construction as a strategic measure to optimize water resource allocation, enhance flood prevention and disaster reduction capabilities, and ensure national water security [1] - The construction of the national water network is also seen as a significant driver for expanding domestic demand, with large investment scale and extensive interconnections across various departments [1] - Emphasis was placed on innovative financing mechanisms to leverage government investment, encourage state-owned enterprises to increase investment, and attract private capital for multi-channel funding [1] Group 2: Cross-Border Trade Facilitation - Cross-border trade facilitation is identified as a key component in creating a first-class business environment, with a focus on enhancing efficient logistics and multi-modal transport coordination [2] - The meeting called for the promotion of green trade and the development of new business models such as cross-border e-commerce, alongside optimizing the regulation of special goods [2] - There is a push to improve smart regulatory services and strengthen quality control of import and export goods to ensure efficient and effective trade management [2] Group 3: Water Supply Management - Water supply is recognized as a vital public service that affects households, with a focus on urban and rural water supply development [2] - The meeting stressed the need for a comprehensive regulatory system from water source to tap, including support for the renewal and upgrading of water supply networks [2] - There is an emphasis on strict compliance with regulations by water supply units, enhancing risk management, and improving emergency response capabilities [2] Group 4: Drug Management Regulations - The meeting underscored the importance of timely revisions to drug management laws to ensure public safety and promote a healthy pharmaceutical industry [3] - There is a call to improve drug research and registration systems, accelerating the review and approval of breakthrough therapies to stimulate industry innovation [3] - Maintaining a high-pressure regulatory environment and enforcing strict quality control across the entire drug supply chain is emphasized to combat illegal activities in the pharmaceutical sector [3]